Detalles de la búsqueda
1.
Rare but clinically important salivary gland-type tumor of the lung: A review.
Jpn J Clin Oncol
; 54(2): 121-128, 2024 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952098
2.
Investigation of a practical assessment index to capture the clinical presentation of cachexia in patients with lung cancer.
Jpn J Clin Oncol
; 54(3): 305-311, 2024 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38213068
3.
Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trial.
BMC Cancer
; 23(1): 6, 2023 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36597021
4.
Real-world data on NGS using the Oncomine DxTT for detecting genetic alterations in non-small-cell lung cancer: WJOG13019L.
Cancer Sci
; 113(1): 221-228, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34704312
5.
Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer.
Invest New Drugs
; 40(1): 106-114, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34495421
6.
Massive digital gene expression analysis reveals different predictive profiles for immune checkpoint inhibitor therapy between adenocarcinoma and squamous cell carcinoma of advanced lung cancer.
BMC Cancer
; 22(1): 154, 2022 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35135489
7.
Survival benefit of using pemetrexed for EGFR mutation-positive advanced non-small-cell lung cancer in a randomized phase III study comparing gefitinib to cisplatin plus docetaxel (WJTOG3405).
Int J Clin Oncol
; 27(9): 1404-1412, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35723758
8.
Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B).
Int J Clin Oncol
; 27(1): 112-120, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34643820
9.
Phase I/II Study of Cisplatin plus Nab-Paclitaxel with Concurrent Thoracic Radiotherapy for Patients with Locally Advanced Non-Small Cell Lung Cancer.
Oncologist
; 26(1): 19-e52, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32918791
10.
Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301.
BMC Cancer
; 21(1): 506, 2021 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33957881
11.
A multi-institutional randomized phase III trial comparing postoperative radiotherapy to observation after adjuvant chemotherapy in patients with pathological N2 Stage III non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1916 (J-PORT study).
Jpn J Clin Oncol
; 51(6): 999-1003, 2021 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33772279
12.
Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer.
Jpn J Clin Oncol
; 51(1): 28-36, 2021 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33147608
13.
Surgical challenges in multimodal treatment of N2-stage IIIA non-small cell lung cancer.
Jpn J Clin Oncol
; 51(3): 333-344, 2021 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33506253
14.
Prognostic impact of geriatric assessment in elderly patients with non-small cell lung cancer: an integrated analysis of two randomized phase III trials (JCOG1115-A).
Jpn J Clin Oncol
; 51(5): 685-692, 2021 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33479759
15.
A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401.
Support Care Cancer
; 29(9): 5237-5244, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33649919
16.
A randomized phase 3 study of maintenance therapy with S-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus S-1 for advanced or relapsed squamous cell carcinoma of the lung (WJOG7512L).
Cancer
; 126(16): 3648-3656, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32484914
17.
Therapies after first-line afatinib in patients with EGFRm+ NSCLC in Japan: retrospective analysis of LUX-Lung 3.
Future Oncol
; 16(4): 49-60, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31922425
18.
KEYNOTE-025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1-positive advanced non-small-cell lung cancer.
Cancer Sci
; 110(3): 1012-1020, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30618179
19.
A Phase II Study of Cisplatin Plus Gemcitabine followed by Maintenance Gemcitabine for Advanced Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group 1302.
Oncology
; 97(6): 327-333, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31412347
20.
Phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L).
Jpn J Clin Oncol
; 49(10): 947-955, 2019 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31242302